Modeling a Snap-Action, Variable-Delay Switch Controlling Extrinsic Cell Death

Citations Over TimeTop 10% of 2008 papers

Abstract

When exposed to tumor necrosis factor (TNF) or TNF-related apoptosis-inducing ligand (TRAIL), a closely related death ligand and investigational therapeutic, cells enter a protracted period of variable duration in which only upstream initiator caspases are active. A subsequent and sudden transition marks activation of the downstream effector caspases that rapidly dismantle the cell. Thus, extrinsic apoptosis is controlled by an unusual variable-delay, snap-action switch that enforces an unambiguous choice between life and death. To understand how the extrinsic apoptosis switch functions in quantitative terms, we constructed a mathematical model based on a mass-action representation of known reaction pathways. The model was trained against experimental data obtained by live-cell imaging, flow cytometry, and immunoblotting of cells perturbed by protein depletion and overexpression. The trained model accurately reproduces the behavior of normal and perturbed cells exposed to TRAIL, making it possible to study switching mechanisms in detail. Model analysis shows, and experiments confirm, that the duration of the delay prior to effector caspase activation is determined by initiator caspase-8 activity and the rates of other reactions lying immediately downstream of the TRAIL receptor. Sudden activation of effector caspases is achieved downstream by reactions involved in permeabilization of the mitochondrial membrane and relocalization of proteins such as Smac. We find that the pattern of interactions among Bcl-2 family members, the partitioning of Smac from its binding partner XIAP, and the mechanics of pore assembly are all critical for snap-action control.

Related Papers

• → Casper Is a FADD- and Caspase-Related Inducer of Apoptosis(1997)396 cited
• → MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclX _L and initiates cell death(1997)234 cited
• → Antagonizing XIAP-mediated caspase-3 inhibition(2004)50 cited
• → Identification of a new caspase homologue: caspase-14(1998)141 cited
• → Comparison of the Smac based peptides and Smac protein in antagonizing caspase‐3 and ‐7 inhibition by the BIR12 and BIR123 domains of XIAP(2011)